1. Home
  2. HYT vs WGS Comparison

HYT vs WGS Comparison

Compare HYT & WGS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Blackrock Corporate High Yield Fund Inc.

HYT

Blackrock Corporate High Yield Fund Inc.

HOLD

Current Price

$8.49

Market Cap

1.4B

Sector

Finance

ML Signal

HOLD

Logo GeneDx Holdings Corp.

WGS

GeneDx Holdings Corp.

HOLD

Current Price

$58.48

Market Cap

1.2B

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
HYT
WGS
Founded
2003
2017
Country
United States
United States
Employees
N/A
1300
Industry
Finance Companies
Retail: Computer Software & Peripheral Equipment
Sector
Finance
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
1.4B
1.2B
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
HYT
WGS
Price
$8.49
$58.48
Analyst Decision
Strong Buy
Analyst Count
0
7
Target Price
N/A
$120.71
AVG Volume (30 Days)
689.0K
1.2M
Earning Date
01-01-0001
05-04-2026
Dividend Yield
9.61%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
$29.98
Revenue Next Year
N/A
$25.92
P/E Ratio
N/A
$1,251.58
Revenue Growth
N/A
N/A
52 Week Low
$8.22
$32.21
52 Week High
$9.88
$170.87

Technical Indicators

Market Signals
Indicator
HYT
WGS
Relative Strength Index (RSI) 40.85 56.82
Support Level $8.38 $56.24
Resistance Level $8.70 $73.46
Average True Range (ATR) 0.06 4.14
MACD -0.01 0.96
Stochastic Oscillator 2.78 69.39

Price Performance

Historical Comparison
HYT
WGS

About HYT Blackrock Corporate High Yield Fund Inc.

BlackRock Corporate High Yield Fund Inc is a diversified, closed-end management investment company. Its primary investment objective is to provide shareholders with current income. The trust's secondary investment objective is to provide shareholders with capital appreciation. Under Normal market conditions, the fund invests at least 80% of its net assets in high-yield securities of corporate issuers and derivatives that provide exposure to those securities or related market risk factors.

About WGS GeneDx Holdings Corp.

GeneDx Holdings Corp focuses on genomics, creating the foundation for providing genomic information at scale and pioneering exome and genome sequencing for rare and ultra-rare genetic pediatric disorders. The company believes exome and genome testing will become the standard for diagnosing genetic disease, with the potential to transform healthcare from reactive to proactive. It aims to advance precision medicine by offering genetic diagnoses at the earliest moments, driving improved outcomes, and fueling discovery with genomic intelligence. Its operating segment mainly provides pediatric and rare disease diagnostics, focusing on whole exome and genome sequencing and, to a lesser extent, data and information services.

Share on Social Networks: